Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Emergent Biosolutions (NYSE: EBS)

$28.57 USD -$0.53 (-1.82%)
Last Price $28.57
Net Change $-0.53 (-1.82%)
Bid $0
Ask Price $0
Open Price $29
Previous Close Price $29.1
High Price $29.19
Low Price $28.52
Number of Trades 1,006
Volume 206,200
Fifty Two Week High $44.38 (2016-06-07)
Fifty Two Week Low $24.47 (2016-11-03)
Average Daily Volume 357,411
Share Outstanding 40,960 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $0.74 (2017-02-23)
2nd Quarter Earnings $0.58 (2016-11-07)
3nd Quarter Earnings $-0.27 (2016-08-04)
4th Quarter Earnings $0.16 (2016-05-05)
PE Ratio $22.38
EPS Growth $-10.35
Recent Earnings $0.74
Annual EPS $1.3
Last Quarter EPS $
Market Capitalization $1.17B
Insider Shareholders % 0.172%
Annual Revenue $0B
No. Shares Outstanding 40,960
Inst. Shareholder % 89.35%
Annual Net Income $0B
TTM Net Profit Margin $103.43
1-Year Return -29.6%
3-Year Return 7.81%
5-Year Return 103.78%
5-Year Revenue Growth 78.79%
5-Year Earnings Growth 145.31%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -10.35%
Dividends per Share $0
Stock Split Ratio
Beta 1.13
EMERGENT BIOSULUTIONS INC. is a leading biopharmaceutical company dedicated to one simple mission - to protect life. EBS develops, manufactures and commercializes vaccines and therapeutics that assist the body's immune system to prevent or treat disease. Their products target infectious diseases and other medical conditions that have resulted in significant unmet or underserved public health needs. Their marketed product, BioThrax' (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection.

EBS News & Stock Updates